The Cancer Institute of New Jersey (CINJ),
an NCI-Designated Comprehensive Cancer Center, is a
matrix style, basic, clinical and population research
center under the auspices of the University of Medicine
and Dentistry of New Jersey-Robert Wood Johnson Medical
School. The Director serves as Associate Dean for Oncology
Programs and is responsible for integrating research
at the medical school with the Robert Wood Johnson
University Hospital, School of Public Health, and several
schools and departments of Rutgers, The State University
of New Jersey.
Established in 1991, CINJ is one of the
Nation’s most rapidly growing cancer centers with a
growth rate in its patient visits of 8% per month.
Starting from a patient base of zero in 1993, CINJ
physicians cared for close to 75,000 patient visits
in 2004.
The research base of CINJ, which is supported
by more than $80 million annually in cancer-related
research grants, is organized into eight programs:
Breast Cancer Research; Cancer Pharmacology/Developmental
Therapeutics; Carcinogenesis and Chemoprevention; Cytokines,
Cytokine Signaling and Cancer; Molecular Mechanisms
of Tumor Growth; Prostate; Population Science, and
Transcriptional Regulation and Oncogenesis.
|
